Home Clinical development Page 19

Clinical development

Clinical Development

Study: Blocking Immune Suppressor Cells in Mice with Glioblastoma Improves Survival

Danielle Garcia - January 27, 2023

Investigational Therapy Shows Promise Against Viral Infections After Stem Cell Transplant

Phase 2b Study Investigates NFX-179 for the Treatment of Cutaneous Neurofibromas

First Patient Randomized in Phase 3 Study Evaluating Radioenhancer NBTXR3 in Head and Neck Cancer

Colorectal cancer

Adagrasib Receives Breakthrough Therapy Designation for Advanced, KRAS-Mutated Colorectal Cancer

Europe Validates Application for Tepotinib for Advanced NSCLC with METex14 Skipping...

Peter Hofland, Ph.D - November 26, 2020

A close up of a newborn baby's foot in the neonatal unit in hospital

U.S. FDA Approves Naxitamab for the Treatment of Neuroblastoma

Peter Hofland, Ph.D - November 26, 2020

EMA Recommends Approval of Tagraxofusp for Blastic Plasmacytoid Dendritic Cell Neoplasm

Editorial Team - November 24, 2020

Pembrolizumab + Axitinib Outperforms Sunitinib in Treatment of Metastatic Renal Cell...

Danielle Garcia - November 22, 2020

Study Shows Pembrolizumab to be Safe in Treatment Metastatic Castration-resistant Prostate...

Danielle Garcia - November 22, 2020

Innovative Risk-assessment Tool Measures Patient’s Local Immune Response to the Cancer

Danielle Garcia - November 22, 2020

Encouraging Clinical Data for Controlled IL-12 for the Treatment of Glioblastoma...

Danielle Garcia - November 20, 2020

Positive Data from Phase I Safety Trial of SDX-7320 in Late...

Editorial Team - November 17, 2020

Colorectal cancer

Isofol Confirms Licensing Agreement with Endo Ventures’ Paladin Labs for...

Editorial Team - November 3, 2020

NIH Starts Clinical Trial with ONC206, a Next-Generation Imipridone

Editorial Team - October 29, 2020

1...181920...24 Page 19 of 24

LATEST NEWS

Study: Blocking Immune Suppressor Cells in Mice with Glioblastoma Improves Survival

Danielle Garcia - January 27, 2023

Stephen Spellman: Mismatched Unrelated Donors – Key to Erasing the Gap in Donor Availability...

Editorial Team - January 18, 2023

New Technologies in Post-surgical Wound Dressings

Brad Greer, JD - January 16, 2023

The Patient Journey Tech Stack: 10 Predictions for 2023

Yishai Knobel - January 16, 2023

Study Confirms: ‘Extreme Lack of Consistency’ Hampers the Potential of Nanosized Medicines

Danielle Garcia - January 12, 2023

Press Releases | Cancer

Java Original Coffee Company to Support The Onco’Zine Brief Radio... January 25, 2023
The Java Original Coffee Company, the home of incredible artisan roasted gourmet coffee, is committed to support the cancer research community as well as select individuals and organizations involved...(PRWeb January 25, 2023)Read the full story at https://www.prweb.com/releases/java_original_coffee_company_to_support_the_oncozine_brief_radio_broadcast_and_podcast/prweb19133000.htm
GO2 for Lung Cancer Addresses Disparities and Health Inequities... January 23, 2023
Through efforts in awareness, education and readily available resources, GO2 for Lung Cancer is helping underserved communities access information and education needed to increase survival rates.(PRWeb January 23, 2023)Read the full story at https://www.prweb.com/releases/go2_for_lung_cancer_addresses_disparities_and_health_inequities_head_on_in_underserved_communities/prweb19126525.htm
$1.3 Billion Liquid Biopsy Market the Present and Future of Clinical... January 20, 2023
Dramatic changes have occurred in the global liquid biopsy market that continue to impact how medical professionals diagnosis, treat, and monitor cancer.(PRWeb January 20, 2023)Read the full story at https://www.prweb.com/releases/1_3_billion_liquid_biopsy_market_the_present_and_future_of_clinical_oncology/prweb19123773.htm